CVE:VM

Voyageur Pharmaceuticals Competitors

C$0.17
0.00 (0.00 %)
(As of 04/9/2021 03:39 PM ET)
Add
Compare
Today's Range
C$0.17
Now: C$0.17
C$0.18
50-Day Range
C$0.17
MA: C$0.20
C$0.23
52-Week Range
C$0.04
Now: C$0.17
C$0.35
Volume177,108 shs
Average Volume323,113 shs
Market CapitalizationC$14.79 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Voyageur Pharmaceuticals (CVE:VM) Vs. GUN, PGE, EAM, SIR, SOI, and NRN

Should you be buying VM stock or one of its competitors? Companies in the industry of "industrial metals & minerals" are considered alternatives and competitors to Voyageur Pharmaceuticals, including Gunpoint Exploration (GUN), Group Ten Metals (PGE), East Africa Metals (EAM), Serengeti Resources (SIR), Sirios Resources (SOI), and Northern Shield Resources (NRN).

Voyageur Pharmaceuticals (CVE:VM) and Gunpoint Exploration (CVE:GUN) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Gunpoint Exploration, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
Gunpoint Exploration0000N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher possible upside, equities research analysts plainly believe Voyageur Pharmaceuticals is more favorable than Gunpoint Exploration.

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Gunpoint Exploration's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
Gunpoint ExplorationN/AN/AN/AC$0.0228.26

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Gunpoint Exploration, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and Gunpoint Exploration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
Gunpoint ExplorationN/AN/AN/A

Voyageur Pharmaceuticals (CVE:VM) and Group Ten Metals (CVE:PGE) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Group Ten Metals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
Group Ten Metals0000N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher possible upside, equities research analysts plainly believe Voyageur Pharmaceuticals is more favorable than Group Ten Metals.

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Group Ten Metals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
Group Ten MetalsN/AN/AN/AC($0.04)-8.84

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Group Ten Metals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and Group Ten Metals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
Group Ten MetalsN/AN/AN/A

Summary

Voyageur Pharmaceuticals beats Group Ten Metals on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals (CVE:VM) and East Africa Metals (CVE:EAM) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and East Africa Metals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
East Africa Metals0000N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher possible upside, equities research analysts plainly believe Voyageur Pharmaceuticals is more favorable than East Africa Metals.

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and East Africa Metals' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
East Africa MetalsN/AN/AN/AC$0.00-87.50

East Africa Metals is trading at a lower price-to-earnings ratio than Voyageur Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Voyageur Pharmaceuticals and East Africa Metals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
East Africa MetalsN/AN/AN/A

Summary

Voyageur Pharmaceuticals beats East Africa Metals on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals (CVE:VM) and Serengeti Resources (CVE:SIR) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.

Profitability

This table compares Voyageur Pharmaceuticals and Serengeti Resources' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
Serengeti ResourcesN/AN/AN/A

Earnings & Valuation

This table compares Voyageur Pharmaceuticals and Serengeti Resources' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
Serengeti ResourcesN/AN/AN/AC($0.06)-8.60

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Serengeti Resources, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and target prices for Voyageur Pharmaceuticals and Serengeti Resources, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
Serengeti Resources0000N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher possible upside, equities research analysts plainly believe Voyageur Pharmaceuticals is more favorable than Serengeti Resources.

Summary

Voyageur Pharmaceuticals beats Serengeti Resources on 3 of the 4 factors compared between the two stocks.

Voyageur Pharmaceuticals (CVE:VM) and Sirios Resources (CVE:SOI) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Voyageur Pharmaceuticals and Sirios Resources' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
Sirios ResourcesN/AN/AN/A

Valuation and Earnings

This table compares Voyageur Pharmaceuticals and Sirios Resources' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
Sirios ResourcesN/AN/AN/AC($0.02)-6.11

Voyageur Pharmaceuticals is trading at a lower price-to-earnings ratio than Sirios Resources, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Voyageur Pharmaceuticals and Sirios Resources, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
Sirios Resources00103.00

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Sirios Resources has a consensus price target of C$0.41, indicating a potential upside of 272.73%. Given Sirios Resources' higher probable upside, analysts plainly believe Sirios Resources is more favorable than Voyageur Pharmaceuticals.

Summary

Sirios Resources beats Voyageur Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

Voyageur Pharmaceuticals (CVE:VM) and Northern Shield Resources (CVE:NRN) are both small-cap basic materials companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Profitability

This table compares Voyageur Pharmaceuticals and Northern Shield Resources' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Voyageur PharmaceuticalsN/AN/AN/A
Northern Shield ResourcesN/AN/AN/A

Valuation and Earnings

This table compares Voyageur Pharmaceuticals and Northern Shield Resources' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voyageur PharmaceuticalsN/AN/AN/AC($0.02)-10.63
Northern Shield ResourcesN/AN/AN/AC($0.01)-11.67

Northern Shield Resources is trading at a lower price-to-earnings ratio than Voyageur Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Voyageur Pharmaceuticals and Northern Shield Resources, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Voyageur Pharmaceuticals00103.00
Northern Shield Resources0000N/A

Voyageur Pharmaceuticals presently has a consensus price target of C$0.39, indicating a potential upside of 129.41%. Given Voyageur Pharmaceuticals' higher probable upside, analysts plainly believe Voyageur Pharmaceuticals is more favorable than Northern Shield Resources.

Summary

Voyageur Pharmaceuticals beats Northern Shield Resources on 3 of the 4 factors compared between the two stocks.


Voyageur Pharmaceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
GUN
Gunpoint Exploration
0.4$0.65flatC$20.88 millionN/A28.26High Trading Volume
PGE
Group Ten Metals
0.4$0.38flatC$20.78 millionN/A-8.84
EAM
East Africa Metals
0.5$0.35flatC$20.76 millionN/A-87.50
SIR
Serengeti Resources
0.6$0.49flatC$20.70 millionN/A-8.60Gap Down
SOI
Sirios Resources
1.8$0.11flatC$20.66 millionN/A-6.11High Trading Volume
Gap Up
NRN
Northern Shield Resources
0.5$0.07flatC$20.35 millionN/A-11.67Gap Up
CUC
C3 Metals Inc. (CUC.V)
0.6$0.06flatC$19.89 millionN/A-4.58Gap Down
TIG
Triumph Gold
0.4$0.18flatC$19.69 millionN/A-3.65Gap Up
FOM
Foran Mining
1.1$1.16flatC$19.59 millionN/A-77.33Analyst Report
News Coverage
GRG
Golden Arrow Resources
0.7$0.17flatC$19.12 millionN/A-3.54
KZD
Kaizen Discovery
0.5$0.05flatC$19.04 millionN/A-2.65Gap Up
RK
Rockhaven Resources
0.6$0.15flatC$18.76 millionN/A-48.33Gap Up
VRB
Vanadiumcorp Resource
0.7$0.09flatC$18.76 millionN/A-22.50Upcoming Earnings
Stornoway Diamond logo
SWY
Stornoway Diamond
0.5N/AN/AC$18.53 millionC$295.40 million-0.03High Trading Volume
IO
Inca One Gold
1.6$0.41flatC$18.43 millionC$27.00 million-5.86
Continental Gold logo
CNL
Continental Gold
0.6$0.09flatC$18.42 millionN/A-0.34
MRZ
Mirasol Resources
0.8$0.56flatC$18.41 millionN/A-5.83
MKR
Melkior Resources
0.6$0.45flatC$18.20 millionN/A-13.91News Coverage
Gap Down
Ascendant Resources logo
ASND
Ascendant Resources
0.9$0.19flatC$17.90 millionC$77.82 million-1.71High Trading Volume
News Coverage
Gap Up
HUD
Hudson Resources
0.4$0.23flatC$17.84 millionN/A-20.45News Coverage
Gap Up
TSN
Telson Mining
0.5$0.38flatC$17.75 millionC$14.63 million-2.25Gap Down
VIPR
Silver Viper Minerals
0.5$0.59flatC$17.64 millionN/A-5.67
ADZ
Adamera Minerals
0.5$0.10flatC$17.32 millionN/A-33.33
IVS
Inventus Mining
0.6$0.16flatC$17.18 millionN/A-15.50News Coverage
Gap Up
PAC
Pacton Gold
0.5$0.68flatC$17.13 millionN/A-2.81Gap Down
GGM
Granada Gold Mine
0.9$0.16flatC$17.02 millionC$-62,721.00-3.69
SWA
Sarama Resources
0.7$0.22flatC$16.29 millionC$156,192.00-7.33
XIM
Ximen Mining
0.5$0.36flatC$15.96 millionN/A-3.26News Coverage
Gap Up
NVM
Nevada Clean Magnesium
0.6$0.07flatC$15.93 millionN/A-7.00Gap Down
LEM
Leading Edge Materials
0.5$0.34flatC$15.91 millionN/A-22.33Gap Up
ABM
Athabasca Minerals
0.6$0.44flatC$15.65 millionC$5.06 million-4.11Gap Up
BMK
MacDonald Mines Exploration
0.6$0.06flatC$15.42 millionC$-74,000.00-1.77Gap Up
PCY
Prophecy Development
0.5N/AN/AC$15.36 millionN/A-0.84High Trading Volume
Gap Down
MMS
Macarthur Minerals
0.5$0.49flatC$15.35 millionC$-5,840,805.00-6.74
CFM
Trillium Gold Mines Inc. (CFM.V)
0.5$0.70flatC$15.27 millionN/A-11.67Gap Down
QTA
Quaterra Resources
0.6$0.11flatC$15.24 millionN/A-22.00Gap Up
RTH
Rathdowney Resources
0.5$0.04flatC$14.55 millionN/A-2.67Gap Up
SYH
Skyharbour Resources
0.7$0.58flatC$14.55 millionN/A-26.36Gap Up
CMU
Comet Industries
0.5$3.25flatC$14.47 millionC$448,929.00-232.14Gap Down
GMA
GéoMégA Resources
0.5$0.44flatC$14.46 millionN/A-29.00Gap Down
WML
Wealth Minerals
0.6$0.27flatC$14.22 millionN/A-7.57Gap Down
RKR
Rokmaster Resources
0.8$0.47flatC$14.21 millionN/A-8.10Gap Up
WRR
Walker River Resources
0.5$0.12flatC$14.04 millionN/A-12.00Gap Up
PCR
Newcore Gold Ltd. (PCR.V)
0.9$0.74flatC$13.99 millionN/A-185.00Gap Down
PE
Pure Energy Minerals
1.1$1.63flatC$13.41 millionN/A-81.50
AGM
Aldridge Minerals
0.5$0.10flatC$13.34 millionN/A-5.59
DBV
Doubleview Capital
0.6$0.08flatC$13.21 millionN/A-37.50Gap Down
OMM
Omineca Mining and Metals
0.4$0.22flatC$13.07 millionN/A-22.00High Trading Volume
Gap Up
PUC
Pancontinental Resources
0.3$0.18flatC$12.91 millionC$5,905.00-18.00News Coverage
SAM
Starcore International Mines
0.9$0.26flatC$12.91 millionC$28.03 million6.50Gap Up
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.